MedPath

Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application

Not Applicable
Not yet recruiting
Conditions
Transitioning Voice of Transgender and Gender Diverse People
Interventions
Other: In-Person Voice Modification Therapy
Registration Number
NCT05815810
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.

Detailed Description

The ultimate objective of this study is to use Community-Based Participatory Research (CBPR) methods to develop an effective user-friendly, health literate, inclusive and accessible mobile application (app) to improve access to gender affirming voice modification training for transgender and gender diverse (TGGD) individuals. The immediate objectives are to understand the needs of TGGD individuals in voice care,and identify barriers to creating a pilot app with evidence-based educational content for VCMT and to evaluate subjective and objective voice outcomes of TGGD participants with app use compared to standard behavioral intervention with a speech pathologist.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Identify as a transgender individual
  • Be 18 years or older
  • Be able to read and write in English
  • Have an iOS Device
Exclusion Criteria
  • Identify as cisgender
  • Experience hoarseness
  • Experiencing any physical pain related to voice use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Transgender and gender diverse (TGGD) individuals receiving standard voice modificationIn-Person Voice Modification TherapyVCMT via speech pathology will be compared to the efficacy of an app-based VCMT program. Participants will undergo VCMT in-person. Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.
Primary Outcome Measures
NameTimeMethod
Change in Transsexual Voice Questionnaire (TVQ) ScoresBaseline, Week 4, Week 11

The Transsexual Voice Questionnaire (TVQ) is a 30-item questionnaire that assesses self-perception of voice in transgender individuals. Responses range from (1) rarely or never to (4) usually or always. Scores range from 30 (no perceived voice difficulty) to 120 (high perceived voice difficulty).

Change in Fundamental FrequencyBaseline, Week 4, Week 11

The acoustic measure fundamental frequency will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax

Change in Transgender Self Evaluation Questionnaire (TSEQ) ScoresBaseline, Week 4, Week 11

The Transgender Self Evaluation Questionnaire (TSEQ) is a 30-item questionnaire that assesses self perception in transgender and gender diverse individuals. Responses range from (1) never (4) always. Scores range from 30 (low voice satisfaction) to 120 (high voice satisfaction)

Change in FormantsBaseline, Week 4, Week 11

The acoustic measure formants will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax

Secondary Outcome Measures
NameTimeMethod
Usability of Mobile Application as measured by the Mobile Application Rating Scale (MARS)Week 11

The Mobile Application Rating Scale (MARS) is a 19-item scale that allows app users to rate the usability of a mobile application. Responses range from 1 (inadequate) to 5 (excellent). Scores range from 19-95 with a score of 19 corresponding to a poor and inadequate app and 95 of an excellent apps with great usability.

Trial Locations

Locations (2)

Weill Cornell Medicine

🇺🇸

New York, New York, United States

Ithaca College

🇺🇸

Ithaca, New York, United States

© Copyright 2025. All Rights Reserved by MedPath